Claus G. Roehrborn

47.3k total citations · 10 hit papers
640 papers, 30.5k citations indexed

About

Claus G. Roehrborn is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Claus G. Roehrborn has authored 640 papers receiving a total of 30.5k indexed citations (citations by other indexed papers that have themselves been cited), including 430 papers in Urology, 358 papers in Pulmonary and Respiratory Medicine and 220 papers in Rheumatology. Recurrent topics in Claus G. Roehrborn's work include Urinary Bladder and Prostate Research (407 papers), Prostate Cancer Diagnosis and Treatment (327 papers) and Pelvic floor disorders treatments (159 papers). Claus G. Roehrborn is often cited by papers focused on Urinary Bladder and Prostate Research (407 papers), Prostate Cancer Diagnosis and Treatment (327 papers) and Pelvic floor disorders treatments (159 papers). Claus G. Roehrborn collaborates with scholars based in United States, Canada and Italy. Claus G. Roehrborn's co-authors include Yair Lotan, Kevin T. McVary, Peter Boyle, Shahrokh F. Shariat, John D. McConnell, J. Curtis Nickel, Steven A. Kaplan, Christopher R. Chapple, Gerald L. Andriole and Reginald C. Bruskewitz and has published in prestigious journals such as New England Journal of Medicine, Cell and JAMA.

In The Last Decade

Claus G. Roehrborn

620 papers receiving 29.2k citations

Hit Papers

The Effect of Finasteride... 1997 2026 2006 2016 1998 2011 2007 2002 2009 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia
    1998 875 citations John D. McConnell, Michael M. Lieber et al. profile →
  2. Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia
    2011 822 citations Claus G. Roehrborn, Steven A. Kaplan et al. The Journal of Urology profile →
  3. Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy
    2007 633 citations Kevin M. Slawin, Claus G. Roehrborn et al. profile →
  4. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
    2002 566 citations Claus G. Roehrborn, J. Curtis Nickel et al. Urology profile →
  5. The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
    2009 528 citations Claus G. Roehrborn, R. Paul Gagnier et al. European Urology profile →
  6. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients
    1998 507 citations Claus G. Roehrborn et al. Urology profile →
  7. Female Stress Urinary Incontinence Clinical Guidelines Panel Summary Report on Surgical Management of Female Stress Urinary Incontinence
    1997 456 citations Roger R. Dmochowski, Claus G. Roehrborn et al. The Journal of Urology profile →
  8. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline
    2018 223 citations Steven A. Kaplan, Claus G. Roehrborn et al. The Journal of Urology profile →
  9. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I—Initial Work-up and Medical Management
    2021 215 citations Steven A. Kaplan, Claus G. Roehrborn et al. The Journal of Urology profile →
  10. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II—Surgical Evaluation and Treatment
    2021 190 citations Steven A. Kaplan, Claus G. Roehrborn et al. The Journal of Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claus G. Roehrborn United States 95 19.8k 16.2k 11.0k 6.3k 5.1k 640 30.5k
Christian G. Stief Germany 73 9.0k 0.5× 10.5k 0.6× 4.5k 0.4× 3.9k 0.6× 5.5k 1.1× 1.1k 24.6k
Herbert Lepor United States 71 8.9k 0.4× 10.2k 0.6× 5.1k 0.5× 3.6k 0.6× 3.7k 0.7× 450 18.5k
Alan J. Wein United States 72 11.8k 0.6× 6.3k 0.4× 6.8k 0.6× 1.6k 0.3× 4.1k 0.8× 695 22.3k
Patrick C. Walsh United States 104 7.0k 0.4× 29.5k 1.8× 9.4k 0.8× 4.9k 0.8× 8.0k 1.5× 577 40.5k
Andrea Salonia Italy 73 6.0k 0.3× 7.7k 0.5× 3.9k 0.4× 5.1k 0.8× 5.3k 1.0× 818 22.5k
Francesco Montorsi Italy 113 14.9k 0.8× 32.9k 2.0× 11.3k 1.0× 8.5k 1.3× 18.0k 3.5× 1.7k 59.5k
Teuvo L.J. Tammela Finland 69 4.5k 0.2× 12.7k 0.8× 3.1k 0.3× 3.5k 0.5× 3.7k 0.7× 669 24.3k
Stephan Madersbacher Austria 56 7.1k 0.4× 5.1k 0.3× 3.9k 0.4× 2.1k 0.3× 3.0k 0.6× 275 12.4k
Michael Marberger Austria 76 5.5k 0.3× 11.7k 0.7× 3.4k 0.3× 2.3k 0.4× 5.0k 1.0× 502 20.6k
Cynthia J. Girman United States 65 5.4k 0.3× 4.0k 0.2× 3.4k 0.3× 3.9k 0.6× 2.1k 0.4× 232 12.9k

Countries citing papers authored by Claus G. Roehrborn

Since Specialization
Citations

This map shows the geographic impact of Claus G. Roehrborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus G. Roehrborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus G. Roehrborn more than expected).

Fields of papers citing papers by Claus G. Roehrborn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claus G. Roehrborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus G. Roehrborn. The network helps show where Claus G. Roehrborn may publish in the future.

Co-authorship network of co-authors of Claus G. Roehrborn

This figure shows the co-authorship network connecting the top 25 collaborators of Claus G. Roehrborn. A scholar is included among the top collaborators of Claus G. Roehrborn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claus G. Roehrborn. Claus G. Roehrborn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaplan, Steven A., Ronald P. Kaufman, Dean Elterman, Bilal Chughtai, & Claus G. Roehrborn. (2025). Extended LUTS medication use following BPH surgical treatment: a US healthcare claims analysis. Prostate Cancer and Prostatic Diseases. 28(4). 913–917. 1 indexed citations
2.
Gold, Samuel, Ramy Goueli, Ryan Mauck, et al.. (2023). Optimal Prostate Cancer Diagnostic Pathways for Men With Prostatomegaly in the MRI Era. Urology. 179. 95–100.
3.
4.
Bhanvadia, Raj, Yair Lotan, Vitaly Margulis, et al.. (2022). Safety and Feasibility of Telehealth Only Preoperative Evaluation Before Minimally Invasive Robotic Urologic Surgery. Journal of Endourology. 36(8). 1070–1076. 4 indexed citations
5.
Jia, Liwei, Douglas W. Strand, Ramy Goueli, et al.. (2022). PSA density is associated with BPH cellular composition. The Prostate. 82(12). 1162–1169. 8 indexed citations
6.
Eure, Gregg, Daniel B. Rukstalis, & Claus G. Roehrborn. (2022). Prostatic Urethral Lift for Obstructive Median Lobes: Consistent Results Across Controlled Trial and Real-World Settings. Journal of Endourology. 37(1). 50–59. 5 indexed citations
7.
Dai, Jessica, Ramy Goueli, Alexander P. Kenigsberg, et al.. (2021). MRI Features Associated with Histology of Benign Prostatic Hyperplasia Nodules: Generation of a Predictive Model. Journal of Endourology. 36(3). 381–386. 4 indexed citations
8.
Creta, Massimiliano, Jean-Nicolas Cornu, Claus G. Roehrborn, et al.. (2020). Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials. European Urology Focus. 7(2). 440–443. 3 indexed citations
9.
Joseph, Diya B., Gervaise H. Henry, Alicia Malewska, et al.. (2020). Urethral luminal epithelia are castration‐insensitive cells of the proximal prostate. The Prostate. 80(11). 872–884. 58 indexed citations
10.
Debruyne, F.M.J., Hermann M. Behre, Claus G. Roehrborn, et al.. (2016). Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men. British Journal of Urology. 119(2). 216–224. 59 indexed citations
11.
Morgan, Monica, Asım Özayar, Justin I. Friedlander, et al.. (2015). An Assessment of Patient Comfort and Morbidity After Robot-Assisted Radical Prostatectomy with Suprapubic Tube Versus Urethral Catheter Drainage. Journal of Endourology. 30(3). 300–305. 17 indexed citations
12.
Morgan, Monica, Selahattin Bedir, Claus G. Roehrborn, Jeffrey A. Cadeddu, & Jodi Antonelli. (2014). A Comparison of Patient Comfort and Satisfaction After Robotic Prostatectomy with Suprapubic Tube Versus Urethral Catheter Drainage. Videourology. 28(4). 1 indexed citations
13.
14.
15.
Roehrborn, Claus G., Gerald L. Andriole, Timothy H. Wilson, Ramiro Castro, & Roger S. Rittmaster. (2010). Effect of Dutasteride on Prostate Biopsy Rates and the Diagnosis of Prostate Cancer in Men with Lower Urinary Tract Symptoms and Enlarged Prostates in the Combination of Avodart and Tamsulosin Trial. European Urology. 59(2). 244–249. 44 indexed citations
16.
Roosen, Alexander, Christopher R. Chapple, Roger R. Dmochowski, et al.. (2009). A Refocus on the Bladder as the Originator of Storage Lower Urinary Tract Symptoms: A Systematic Review of the Latest Literature. European Urology. 56(5). 810–820. 99 indexed citations
17.
Roehrborn, Claus G. & Paul S. Ray. (2006). Efficacy and tolerability of the dual 5α-reductase inhibitor, dutasteride, in the treatment of benign prostatic hyperplasia in African-American men. Prostate Cancer and Prostatic Diseases. 9(4). 432–438. 9 indexed citations
18.
Shariat, Shahrokh F., Yair Lotan, Hossein Saboorian, et al.. (2004). Survivin expression is associated with features of biologically aggressive prostate carcinoma. Cancer. 100(4). 751–757. 153 indexed citations
19.
Roehrborn, Claus G., John D. McConnell, Michael M. Lieber, et al.. (1999). Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. Urology. 53(3). 473–480. 269 indexed citations
20.
Djavan, Bob, M. Fakhari, Claus G. Roehrborn, & Michael Marberger. (1998). Metabolic consequences of urinary diversion with intestinal segments.. PubMed. 4(4). 177–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian G. Stief Breakdown of academic impact, for papers by Herbert Lepor Breakdown of academic impact, for papers by Alan J. Wein Breakdown of academic impact, for papers by Patrick C. Walsh Breakdown of academic impact, for papers by Andrea Salonia Breakdown of academic impact, for papers by Francesco Montorsi Breakdown of academic impact, for papers by Teuvo L.J. Tammela Breakdown of academic impact, for papers by Stephan Madersbacher Breakdown of academic impact, for papers by Michael Marberger Breakdown of academic impact, for papers by Cynthia J. Girman
Rankless by CCL
2026